SCIENTIFIC PUBLICATIONS

Our medical oncologists and laboratory investigators are at the forefront of investigations into the causes of cancer and the search for novel treatments.

We have published the results of our investigations, often in collaboration with some of the most prestigious international institutions, in renowned medical journals such as the New England Journal of Medicine, Clinical Cancer Research, and many others.

CONSULT OUR SCIENTIFIC PUBLICATIONS

01/12/2015

Immunotherapy meets targeted therapy: will this team end the war against cancer?

AUTHORS Morales-Espinosa D, García-Román S, Teixidó C, Karachaliou N, Rosell R.

PUBLICATION Transl Lung Cancer Res. 2015 Dec;4(6):752-5.

READ ARTICLE

01/12/2015

Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role

AUTHORS Santarpia M, González-Cao M, Viteri S, Karachaliou N, Altavilla G, Rosell R.

PUBLICATION Transl Lung Cancer Res. 2015 Dec;4(6):728-42.

READ ARTICLE

01/12/2015

Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity

AUTHORS Pilotto S, Molina-Vila MA, Karachaliou N, Carbognin L, Viteri S, González-Cao M, Bria E, Tortora G, Rosell R.

PUBLICATION Transl Lung Cancer Res. 2015 Dec;4(6):721-7.

READ ARTICLE

01/12/2015

Platelets and their role in cancer evolution and immune system

AUTHORS Karachaliou N, Pilotto S, Bria E, Rosell R.

PUBLICATION Transl Lung Cancer Res. 2015 Dec;4(6):713-20.

READ ARTICLE

01/12/2015

Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

AUTHORS Pilotto S, Carbognin L, Karachaliou N, Garassino M, Cuppone F, Petraglia S, Rosell R, Tortora G, Bria E.

PUBLICATION Transl Lung Cancer Res. 2015 Dec;4(6):704-12.

READ ARTICLE